Mark Pomerantz

16PUBLICATIONS
243CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPacific Peoples social determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 13, 2025
The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

Takafumi N Yamaguchi, Kathleen E Houlahan, Helen Zhu

|Oct 25, 2024
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer.

Konrad H Stopsack, Joseph Vijai, Michael Conry

|Jun 17, 2024
Insulin resistance during androgen deprivation therapy in men with prostate cancer.

Shehzad Basaria, Mary-Ellen Taplin, Marie McDonnell

|Mar 29, 2024
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.

Atish D Choudhury, Lucia Kwak, Alexander Cheung

|Jan 08, 2024
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.

Naiyu Chen, Colleen B McGrath, Caroline I Ericsson

|Jan 01, 2024
Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial.

Rana R McKay, Wanling Xie, Xiaoyu Yang

Pageof 3

Frequent Collaborators

3 joint publications

Philip W Kantoff

3 joint publications

Christopher Sweeney

3 joint publications

Rana R McKay

3 joint publications

Toni K Choueiri